IHE ETF
iShares US Pharmaceutical ETF
IHE ETF Overview
IHE ETF (iShares US Pharmaceutical ETF) is managed by iShares by BlackRock (US) with $1.63B in net assets. IHE expense ratio is 0.37%, holding 60 positions across sectors including Health Care, Financials, Consumer Staples. Inception date: 2006-05-01.
IHE performance shows a YTD return of 20.52%. The 1-year return is 57.35% and the 5-year return is 11.61%. IHE dividend yield stands at 1.43%, paid quarterly.
IHE top holdings include Johnson & Johnson - Common (22.6%), Eli Lilly & Co. (22.0%), Merck & Company Inc (4.4%), Viatris Inc. (4.4%), Royalty Pharma 3.55 09/02/2050 (4.3%). Go to all IHE holdings, IHE sectors, or IHE dividends.
IHE can be compared against other funds. Use IHE overlap to find shared positions, or IHE vs another fund for a side-by-side view. IHE alternatives are available via the screener, along with tax-loss harvesting opportunities.